Net Cash Provided by (Used in) Operating Activities |
-150K |
USD |
-667% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
155K |
USD |
+569% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
2.7B |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
1.02B |
shares |
+16.3% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
4.87K |
USD |
+35.5% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
7.49K |
USD |
-32.3% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Valuation Allowance |
714K |
USD |
+2% |
Q4 2023 |
FY 2023 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-54.8K |
USD |
-97.1% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
714K |
USD |
+2% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
15M |
shares |
+50% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Authorized |
15M |
shares |
+50% |
Q2 2024 |
Q2 2024 |
Additional Paid in Capital |
8.61M |
USD |
+166% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Outstanding |
15M |
shares |
+50% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |